FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of cyclic amines and their using as medicinal agents, namely, to compound represented by the general formula (I) 
, its pharmaceutically acceptable acid-additive salt or its pharmaceutically acceptable C1-C6-alkyl-additive salt; R1 is phenyl, C3-8-cycloalkyl, aromatic heterocycle with 1-3 heteroatoms taken among O, S, N or their combination. Indicated groups can be condensed with benzene ring or aromatic heterocyclic group with heteroatoms taken among O, S or N, or their combination and they comprise different substituents also. EFFECT: valuable properties of compounds. 54 cl, 52 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SPHINGOSINE-1-PHOSPHATE BINDING INHIBITOR | 2007 |
|
RU2395499C2 |
| SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUND, METHOD OF PHARMACOLOGICAL EFFECT, METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY, INHIBITION OF LIPID PEROXIDES PRODUCTION OR BLOOD SUGAR LEVEL DECREASE | 1998 |
|
RU2196141C2 |
| INHIBITORS OF FACTOR VIIA | 2000 |
|
RU2248359C2 |
| DERIVATIVES OF N-SUBSTITUTED INDOLE-3-GLYOXYLAMIDE AS ANTITUMOR MEDICINAL AGENT AND AGENT INHIBITING ANGIOGENESIS (VARIANTS) AND ANTITUMOR MEDICINAL AGENT (VARIANTS) | 2000 |
|
RU2282444C2 |
| PRODUCT COMPRISING AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF NO-SYNTHASE IN COMBINATION WITH AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF PHOSPHOLIPASE A | 2000 |
|
RU2256465C2 |
| 2,5,7-SUBSTITUTED OXAZOLPYRIMIDINE DERIVATIVES | 2011 |
|
RU2557246C2 |
| DERIVATIVES OF (THIO)UREA INHIBITING VIIa FACTOR, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2286337C2 |
| CYCLIC AMINE COMPOUND | 2005 |
|
RU2379307C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2323004C2 |
| DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2214997C2 |
